Showing posts with label open data. Show all posts
Showing posts with label open data. Show all posts

15 February 2023

Incoming: Spare Slots for Freelance Work in 2023


I will soon have spare slots in my freelance writing schedule for regular weekly or monthly work, and major projects. Here are the main areas that I've been covering, some for nearly three decades. Any commissioning editors interested in talking about them or related subjects, please contact me at glyn.moody@gmail.com. I am also available to speak on these topics at relevant conferences around in the world, something I have done many times in the past. 

Privacy, Surveillance, Encryption, Freedom of Speech 

Over the last decade, I have written hundreds of articles about these crucial areas, for Techdirt, Privacy News Online, and Ars Technica. Given the increasing challenges facing society in these areas, they will remain an important focus for my work in the future. 

Copyright

I have also written many hundreds of articles about copyright. These have been mainly for Techdirt, where I have published nearly 1,900 posts, CopyBuzz, and Walled Culture. Most recently, I have written a 300-page book, also called Walled Culture, detailing the history of digital copyright, its huge problems, and possible solutions. Free ebook versions of its text are available

EU Tech Policy and EU Trade Agreements: DSA, DMA, TTIP, CETA 

I have written about EU tech policy for CopyBuzz, focussing on the EU Copyright Directive, and for Privacy News Online, dealing with major initiatives such as the Digital Services Act, the Digital Markets Act, and the Artificial Intelligence Act. Another major focus of my writing has been so-called "trade agreements" like TTIP, CETA, TPP and TISA. "So-called", because they go far beyond traditional discussions of tariffs, and have major implications for many areas normally subject to democratic decision making, notably tech policy. In addition to 51 TTIP Updates that I originally wrote for Computerworld UK. I have covered this area extensively for Techdirt and Ars Technica, including a major feature on TTIP for the latter. 

Free Software/Open Source

I started covering this topic in 1995, wrote the first mainstream article on Linux for Wired in 1997, and the first (and still only) detailed history of the subject, Rebel Code: Linux and the Open Source Revolution in 2001, for which I interviewed the world’s top 50 hackers at length. 

Open Access, Open Data, Open Science, Open Government, Open Everything 

As the ideas underlying openness, sharing and online collaboration have spread, so has my coverage of them, particularly for Techdirt. I wrote one of the most detailed histories of Open Access, for Ars Technica, and its history and problems also form Chapter 3 of my book Walled Culture, mentioned above. 

Europe 

As a glance at some of my 580,000 (sic) posts to Twitter, and 18,000 posts on Mastodon, will indicate, I read news sources in a number of languages (Italian, German, French, Russian, Spanish, Portuguese, and Georgian in descending order of capability.) This means I can offer a fully European perspective on any of the topics above - something that may be of interest to publications wishing to provide global coverage that goes beyond purely anglophone reporting. The 25,000 or so followers that I have across these social networks also means that I can push out links to my articles, something that I do as a matter of course to boost their readership and encourage engagement. 


London 2023

08 January 2018

Incoming: Spare Slots for Freelance Work in 2018


I will soon have spare slots in my freelance writing schedule for regular weekly or monthly work, and major projects. Here are the main areas that I've been covering, some for more than two decades. Any commissioning editors interested in talking about them or related subjects, please contact me at glyn.moody@gmail.com (PGP available).  I am also available to speak on these topics at relevant conferences.

Surveillance, Encryption, Privacy, Freedom of Speech

For the last two years, I have written hundreds of articles about these crucial areas, for Ars Technica UK (http://arstechnica.co.uk/author/glyn_moody/), Privacy News Online (https://www.privateinternetaccess.com/blog/author/glynmoody/) and Techdirt (https://www.techdirt.com/user/glynmoody). Given the challenges facing society this year, they are likely to be an important focus for my work in 2018.

China

Another major focus for me this year will be China. I follow the world of Chinese IT closely, and have written numerous articles on the topic. Since I can read sources in the original, I am able to spot trends early and to report faithfully on what are arguably some of the most important developments happening in the digital world today.

Free Software/Open Source

I started covering this topic in 1995, wrote the first mainstream article on Linux for Wired in 1997 (https://www.wired.com/1997/08/linux-5/), and the first (and still only) detailed history of the subject, Rebel Code (https://en.wikipedia.org/wiki/Rebel_Code) in 2001, where I interviewed the top 50 hackers at length. I have also written about the open source coders and companies that have risen to prominence in the last decade and a half, principally in my Open Enterprise column for Computerworld UK, which ran from 2008 to 2015.

Open Access, Open Data, Open Science, Open Government, Open Everything

As the ideas underlying openness, sharing and online collaboration have spread, so has my coverage of them. I wrote one of the most detailed histories of Open Access, for Ars Technica (http://arstechnica.com/science/2016/06/what-is-open-access-free-sharing-of-all-human-knowledge/).

Copyright, Patents, Trade Secrets

The greatest threat to openness is its converse: intellectual monopolies, which prevent sharing. This fact has led me to write many articles about copyright, patents and trade secrets. These have been mainly for Techdirt, where I have published over 1,500 posts, and also include an in-depth feature on the future of copyright for Ars Technica (http://arstechnica.co.uk/tech-policy/2015/07/copyright-reform-for-the-digital-age/).

Trade Agreements - TTIP, CETA, TISA, TPP

Another major focus of my writing has been so-called "trade agreements" like TTIP, CETA, TPP and TISA. "So-called", because they go far beyond traditional discussions of tariffs, and have major implications for many areas normally subject to democratic decision making. In addition to 51 TTIP Updates that I originally wrote for Computerworld UK (http://opendotdotdot.blogspot.nl/2016/01/the-rise-and-fall-of-ttip-as-told-in-51.html), I have covered this area extensively for Techdirt and Ars Technica UK, including a major feature on TTIP (http://arstechnica.co.uk/tech-policy/2015/05/ttip-explained-the-secretive-us-eu-treaty-that-undermines-democracy/) for the latter.

Europe

As a glance at some of my 318,000 (sic) posts to Twitter, identi.ca and Google+ will indicate, I read news sources in a number of languages (Italian, German, French, Spanish, Russian, Portuguese, Dutch, Greek, Swedish in descending order of capability.) This means I can offer a fully European perspective on any of the topics above - something that may be of interest to publications wishing to provide global coverage that goes beyond purely anglophone reporting. The 30,000 or so followers that I have across these social networks also means that I can push out links to my articles, something that I do as a matter of course to boost their readership.

29 July 2014

The European Commission's Great TTIP Betrayal

When the European Commission was laying the foundations for the Transatlantic Trade and Investment Partnership - TTIP, also known as TAFTA by analogy with NAFTA - it was doubtless hoping that the public would ignore it, just as it had ignored countless other boring trade agreements. But of course TTIP is not principally a trade agreement: it aims to go far beyond "merely" liberalising trade by attacking "behind the border" barriers.

These "non-tariff barriers" - NTBs - are what you and I call health and safety regulations, environmental protection, labour laws etc. They are all things that make life a more pleasant place - especially in Europe, where they are particularly strong; but they are also things that decrease the profits of companies that must obey them. TTIP is about removing as many of these as possible, so as to boost corporate profits.

Of course, that's not how the European Commission can frame things. Indeed, after the public began to wake up to what TTIP really meant, the commissioner responsible for leading the TTIP negotiations, Karel De Gucht, was forced to make high-profile statements denying that the agreement would lower standards:

Let me be clear on this very important point: we are not lowering standards in TTIP. Our standards on consumer protection, on the environment, on data protection and on food are not up for negotiation. There is no “give and take” on standards in TTIP.

Simple logic tells us that this can't possibly be true. If two completely different regulatory systems are to be brought together - the avowed aim of TTIP - there are only three possibilities. Either the side with the higher standards levels down; the side with the lower standards levels up; or there is mutual recognition of each other's standards. The US has clearly stated that it is not prepared to level up - it won't accept EU bans on chlorine-washed chickens, hormone beef or GMOs.


Mutual recognition, although apparently different, is in fact identical to levelling down: if both regulations are acceptable, manufacturers working to the higher set will be at a disadvantage commercially. They will therefore either relocate their factories to the country with the lower standards, which are cheaper to implement, or lobby for the higher standards to be levelled down, threatening either to leave the country, or shut down. Politicians always give in to this kind of blackmail, so EU standards would inevitably be lowered to those of the US as a result of mutual recognition.


But it has become increasingly clear that there is another way for the European Commission to circumvent its own promises that TTIP will not lower standards. The trick here is that the European Commission will lower standards *before* TTIP; so technically speaking it is not TTIP that brings about that dilution - it occurred "independently". Thus the Commission will be able to put its hand on its heart and swear blind that it kept its word not to sell out EU standards in TTIP, while at the same time changing the regulatory context in such a way that the US will be able to export things that are currently banned by strict EU legislations.


We're seeing more and more examples of this. Here, for example, is how new GMO regulations will allow US companies to bring in GM food:

Genetically modified crops could be grown in the UK from next year after the EU ministers relaxed laws on the controversial farming method.
Maize that has been engineered to resist weedkiller is the first to be approved but all commercial GM crops will not be given the green light for another 10 years.
Owen Patterson, the Environment Secretary, has long supported the introduction of GM crops in the UK and voted in favour of the changes on Thursday.
He said: “This is a real step forward in unblocking the dysfunctional EU process for approving GM crops, which is currently letting down our farmers and stopping scientific development.


Here's how the EU's Fuel Quality Directive, designed to discourage the use of highly-polluting carbon fuels, is being drastically weakened [.pdf]:

Since its inception in 2009, the Fuel Quality Directive (FQD), a European Union regulation aimed at reducing the climate impact of transport fuels, has been attacked by powerful lobby interests that do not want the EU to take action to curtail the use of particularly greenhouse gas intensive fossil fuels.
...
these attempts to weaken this landmark climate policy seem to have been successful. If recent media reports are correct, the European Commission has decided to significantly weaken the FQD and align its regulatory standards with the wishes of the oil industry, the US trade negotiators [for TTIP] and the Canadian government. Compared to a previous proposal from 2011, it would be considerably less effective in cleaning up Europe’s transport fuels and preventing the most climate polluting fuels, including tar sands, from entering Europe.

Most recently, we have learned that the European Commission is preparing to allow endocrine disruptors in pesticides - another key demand from the US side in TTIP. Unfortunately, the source for this information, Inside US Trade, is behind a paywall, so I can't give a link, but will just quote a couple of key passages:

One of the options proposed by the commission in a June 17 "roadmap" is to shift from the current EU approach of banning the use of all endocrine disruptors in pesticides toward a model that could allow them to be used as long as certain steps are taken to mitigate the risk. 

This risk assessment-based model is favored by the U.S. and EU pesticide industries and is the approach employed under the U.S. Environmental Protection Agency's "Endocrine Disruptor Screening Program." Such a model seeks to evaluate both whether a hazard exists and if it can be mitigated by limiting exposure, in order to allow the marketing of an otherwise dangerous product.


As you can see, this amounts to abandoning the EU's Precautionary Principle, and adopting the completely different risk-based approach of the US. Aside from the fact that this shows that the European Commission's promises that standards would not fall, that the EU would not be forced to adopt US approaches, and that public health in Europe would always be safeguarded, were worthless, this also disregards the EU's Treaty of Lisbon, which explicitly states:



Union policy on the environment shall aim at a high level of protection taking into account the diversity of situations in the various regions of the Union. It shall be based on the precautionary principle and on the principles that preventive action should be taken, that environmental damage should as a priority be rectified at source and that the polluter should pay.


What's particularly interesting about the latest move by the European Commission is that the industry sources in the article quoted above point out that it represents a move to a "science-based" approach, something they have been demanding (note, too, that Owen Paterson also spoke of "scientific development" in the passage quoted above.) 

This is part of consistent campaign to paint the Precautionary Principle as "unscientific". In fact, this reframing is precisely what I predicted would happen a year ago. The key point is that "science" in the abstract does not exist: there is a continuum of good science and bad science - where the latter often includes experiments carried out by corporate scientists who miraculously produce results that match their paymaster's desires.



It's not just me saying this. Yesterday the following article appeared in the Guardian on the subject of pesticide research - the area that the European Commission wants to overhaul radically, moving towards a "science-based" approach:

Criticial future research on the plight of bees risks being tainted by corporate funding, according to a report from MPs published on Monday. Pollinators play a vital role in fertilising three-quarters of all food crops but have declined due to loss of habitat, disease and pesticide use. New scientific research forms a key part of the government’s plan to boost pollinators but will be funded by pesticide manufacturers.


That is, as I pointed out, when companies pay for research, they tend to get the answers they want.



When it comes to research on pesticides, the Department of Environment, Food and Rural Affairs (Defra) is content to let the manufacturers fund the work,” said EAC chair Joan Walley. “This testifies to a loss of environmental protection capacity in the department responsible for it. If the research is to command public confidence, independent controls need to be maintained at every step. Unlike other research funded by pesticide companies, these studies also need to be peer-reviewed and published in full”.



This again is something that I advocated last year. If companies want us to take their results seriously - and in principle I don't have problem with that, provide the science is sound and independent - then they must publish their findings in peer-reviewed journals and, crucially, publish *all* of their results as open data, for anyone to check and explore further. If they won't do that, we will know that they have something to hide.



In the meanwhile, expect the European Commission to start invoking "science-based" approaches to policy more and more, and that these strangely always mean that the European Union should lower its standards to those of the US, which already uses this "tainted" approach.



But however the Commission wants to package this massive shift, and whatever lipstick it puts on this particular pig (sorry, pigs, nothing personal), this is a fundamental betrayal at the very deepest level. It is truly disgraceful - not to mention ungrateful - that at every turn the European Commission seems to prefer to serve US corporations rather than the European public that pays the Commissioners' not-inconsiderable salaries. It's another reason why the whole of TTIP - not just the already terminal ISDS - must be rejected.



Follow me @glynmoody on Twitter or identi.ca, and +glynmoody on Google+

24 July 2014

Why Opening Up Clinical Trials Data Is Good For Pharma Companies Too

Earlier this year we wrote about how AbbVie, the pharma company spun out of Abbott Laboratories, had gone to court to stop the European Medicines Agency (EMA) from releasing clinical trials information about one of its drugs. Despite what AbbVie claimed, this was not commercially sensitive in any way, but simply basic data about safety and efficacy. 

On Techdirt.

24 November 2013

Of Surveillance Debates and Open Clinical Data

Revelations about the staggering levels of online surveillance that are now routine in this country have been met with a stunning silence from the UK government. There's an important meeting tomorrow where three MPs from the main parties are trying to get some kind of debate going on this crucial issue. It would be helpful if you could ask your MP to participate. Here's what I've written:

On Open Enterprise blog.

Open Clinical Trials: Please Write to Health Minister

I first wrote about the importance of open clinical trials two years ago. More recently, I urged people to contact their MEPs for a crucial vote that was taking place in one of the committees in the European Parliament. The AllTrials site, which is coordinating the fight to obtain access to this vital public health information, now asks for help during another stage in the battle for open data:

On Open Enterprise blog.

26 October 2013

Tell Old Pharaoh: Let My Postcodes Go

The story of open data in the UK has been fairly uplifting in recent years, as more and more public datasets are released under liberal licences. Even the big holdouts - things like Ordnance Survey - have gradually loosened their grip. The same is true for the Postcode Address File (PAF), which has a surprising long history:

On Open Enterprise blog.

19 September 2013

EU Vote on Clinical Trials Data - Please Contact MEPs Now

I've written a few times about open data in the context of clinical trials - the information that must be provided when new drugs seek approval. As I noted, there is a growing movement to make such basic safety data freely available, the idea being that it could then be analysed by third parties, perhaps finding new applications of drugs, overlooked problems, or even wilful concealing of adverse effects

On Open Enterprise blog.

18 September 2013

Reading Shakespeare: the Next Act of Open Data

As readers of this blog will have noticed, much of the most innovative work in the field of openness is taking place in open data. One of the largest stores of data is held by government, and the argument for opening it up where possible is strong: after all, we, the public, paid for this data, so it is only right that we, the public, should have access to it. 

On Open Enterprise blog.

European Court Puts Release Of Drug Safety Data On Hold

Last month Techdirt wrote about the case of the giant pharma company AbbVie seeking to prevent the European Medicines Agency from releasing basic health safety data that AbbVie claims contains commercially sensitive information. Unfortunately, an interim injunction has just been granted to that effect

On Techdirt.

Open Data, Creative Destruction and Money

Nearly three years ago, I wrote an article exploring why at that time there were no billion-dollar companies (since then, Red Hat has finally broken through this barrier). Here's the key point:

On Open Enterprise blog.

20 July 2013

Public Domain Human Genome Project Generated More Research And More Commercial Activity Than Proprietary Competitor

Traditionally, there has been a blithe assumption that more innovation occurs when patents are granted than when they are not. But as Techdirt has reported, people are finally beginning to call that into question. A forthcoming paper from an economist at MIT, Heidi Williams, provides another example of where that is not the case: in the field of genomics (via @gsDetermination). 

On Techdirt.

Clinical Trials Must be Open Data: Please Contact MEPs

Back in February, I noted that the UK's investigation into making clinical trial data freely available was somewhat subsidiary to the EU's major initiative on the same subject. The battle there between those who wish to keep clinical trials data secret, for fear that it might show pharma companies in a bad light, and those who believe that it must be released to save money and - more importantly - save lives is now increasingly fierce.

On Open Enterprise blog.

14 April 2013

EU Proposal for (Nearly) Open Data [Update]


Update: Maël Brunet has pointed out that the press release I linked to below is from 2011; what was actually announced yesterday was that the EU Council's 'Coreper' committee (EU Committee of Member States' Permanent Representatives) has now endorsed the measures announced there. So, nothing has changed from what I wrote below, but another hurdle has been cleared in making the open data initiative happen. All that remains is for the European Parliament to agree, and the rules will come into force. Unfortunately, it seems unlikely that any amendments will be included at this stage, so it looks like we only get "almost" open data....

31 March 2013

Open Source: That's the Way to Do It

Although the use of open source by the UK government has an unhappy history (and one that certainly isn't finished), one ray of hope comes from Gov.uk, as I've noted before. The driving force behind that site is the Government Digital Service (GDS), and on its blog there's a particularly interesting post by Mike Bracken, who rejoices in the splendid title of "Executive Director of Digital in the Cabinet Office." 

On Open Enterprise blog.

Giant Pharma Company Claims Releasing Data On Drug Safety Is Illegal As It's Confidential And 'Commercially Sensitive'

One of the initiatives gaining momentum around the world is open data -- the idea that, for example, non-personal data affecting the public should be made freely available. That's partly to improve transparency, so that citizens are more informed about what is happening, and partly to stimulate new kinds of business that build products and services based on that data. 

On Open Enterprise blog.

If It Comes With A Gagging Clause, It's Not Open Data

One of the richest seams of open data concerns transport. After all, by their very nature, transport systems generate huge amounts of new data every day -- times, routes, travel options. Similarly, huge numbers of people use multiple means of transport, which means there is a big potential audience for analyses of that data. And it's definitely in the interest of transport operators to make that information freely available so that developers can use it in new ways, since that is likely to make traveling easier, and lead to increased custom. 

On Techdirt.

10 March 2013

Select Committee Inquiry into Clinical Trials Data

Back in November last year, I wrote about a particular class of open data - that regarding clinical trials data. I pointed out that of all open data, it is arguably the most important, because it can literally save lives - huge numbers of them. That post was by way of a taster for future columns - like this one - which touch on this area, since I believe it will become one of the most important battlegrounds for openness in the next few years.

On Open Enterprise blog.

The Continuing Disaster Of Open Government In Germany

Recently, Techdirt noted that the European "database right" could pose a threat to releasing public data there. But that assumes that central governments are at least trying to open things up. A splendid piece by Sebastian Haselbeck on the Open Gov Germany blog, with the self-explanatory title "German government screws up open data," underlines that things can fail because the government itself sabotages transparency moves. 

On Techdirt.

09 March 2013

Europe's 'Database Right' Could Throttle Open Data Moves There

One of the more benighted moves by the European Union was the introduction of a special kind of copyright for databases in 1996: not for their contents, but for their compilation. This means that even if the contents are in the public domain, the database may not be. Thanks to a recent court judgment in France, this "database right" now threatens to become a real danger for the burgeoning open data movement in Europe (original in French). 

On Techdirt.